Pedro Lins Palmeira Filho
Directeur/Bestuurslid bij Recepta Biopharma SA
Profiel
Pedro Lins Palmeira Filho is currently a Director at Recepta Biopharma SA and Biozeus Biopharmaceutical SA.
Actieve functies van Pedro Lins Palmeira Filho
| Bedrijven | Functie | Begin |
|---|---|---|
Recepta Biopharma SA
 Recepta Biopharma SA BiotechnologyHealth Technology Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil. | Directeur/Bestuurslid | - |
Biozeus Biopharmaceutical SA
 Biozeus Biopharmaceutical SA Miscellaneous Commercial ServicesCommercial Services Biozeus Biopharmaceutical SA operates as a drug development company. It engages in the identifying early-stage drug candidates from Brazilian research institutions and develop them into new therapies for improving and saving lives, worldwide. The company is headquartered in Rio de Janeiro, Brazil. | Directeur/Bestuurslid | 01-01-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Recepta Biopharma SA
Recepta Biopharma SA BiotechnologyHealth Technology Recepta Biopharma SA researches and develops drugs for cancer treatment. It is a biotechnology company which is engaged in the research, development, production and marketing of human antibodies for the diagnosis and treatment of human cancer. The company was founded in 2006 and is headquartered in Sao Paulo, Brazil. | Health Technology |
Biozeus Biopharmaceutical SA
Biozeus Biopharmaceutical SA Miscellaneous Commercial ServicesCommercial Services Biozeus Biopharmaceutical SA operates as a drug development company. It engages in the identifying early-stage drug candidates from Brazilian research institutions and develop them into new therapies for improving and saving lives, worldwide. The company is headquartered in Rio de Janeiro, Brazil. | Commercial Services |
